Elizabeth Kovacs
Concepts (516)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Burns | 55 | 2023 | 238 | 16.610 |
Why?
| Ethanol | 52 | 2023 | 548 | 9.110 |
Why?
| Alcoholic Intoxication | 15 | 2023 | 62 | 6.060 |
Why?
| Alcohol Drinking | 22 | 2023 | 656 | 4.100 |
Why?
| Pneumonia | 12 | 2023 | 569 | 3.850 |
Why?
| Aging | 22 | 2023 | 1624 | 3.490 |
Why?
| Alcoholism | 21 | 2023 | 717 | 3.360 |
Why?
| Inflammation | 29 | 2023 | 2485 | 3.170 |
Why?
| Lung Transplantation | 15 | 2019 | 246 | 2.980 |
Why?
| Immunity, Innate | 12 | 2017 | 723 | 2.760 |
Why?
| Interleukin-6 | 16 | 2023 | 676 | 2.540 |
Why?
| Neutrophils | 16 | 2022 | 1163 | 2.240 |
Why?
| Macrophages, Alveolar | 9 | 2022 | 351 | 2.230 |
Why?
| Lung | 23 | 2022 | 3595 | 2.160 |
Why?
| Liver Diseases | 5 | 2021 | 263 | 2.150 |
Why?
| Burns, Inhalation | 5 | 2020 | 9 | 2.040 |
Why?
| Intestines | 4 | 2022 | 322 | 2.020 |
Why?
| Binge Drinking | 8 | 2023 | 32 | 2.000 |
Why?
| Wound Healing | 11 | 2015 | 259 | 1.980 |
Why?
| Macrophages | 13 | 2016 | 1267 | 1.950 |
Why?
| Mice | 61 | 2023 | 14934 | 1.940 |
Why?
| Animals | 89 | 2023 | 31884 | 1.880 |
Why?
| Gastroesophageal Reflux | 10 | 2014 | 233 | 1.790 |
Why?
| Cytokines | 18 | 2023 | 1843 | 1.780 |
Why?
| Bronchoalveolar Lavage Fluid | 15 | 2018 | 590 | 1.760 |
Why?
| Gastrointestinal Microbiome | 6 | 2023 | 502 | 1.690 |
Why?
| Dysbiosis | 3 | 2023 | 146 | 1.680 |
Why?
| Lung Diseases | 9 | 2018 | 703 | 1.650 |
Why?
| Mice, Inbred C57BL | 30 | 2023 | 4718 | 1.630 |
Why?
| Age Factors | 14 | 2022 | 2900 | 1.470 |
Why?
| Phagocytosis | 7 | 2016 | 352 | 1.450 |
Why?
| Smoke Inhalation Injury | 6 | 2013 | 19 | 1.430 |
Why?
| Neutrophil Infiltration | 8 | 2016 | 94 | 1.380 |
Why?
| Bacterial Translocation | 6 | 2016 | 36 | 1.290 |
Why?
| Respiratory Aspiration | 4 | 2013 | 31 | 1.280 |
Why?
| Public Opinion | 4 | 2023 | 59 | 1.250 |
Why?
| Pseudomonas Infections | 4 | 2016 | 186 | 1.240 |
Why?
| Macrophage Activation | 6 | 2019 | 164 | 1.170 |
Why?
| Central Nervous System Depressants | 3 | 2015 | 82 | 1.160 |
Why?
| Disease Models, Animal | 19 | 2023 | 3547 | 1.160 |
Why?
| Immune System | 5 | 2017 | 172 | 1.070 |
Why?
| Bronchiolitis Obliterans | 6 | 2014 | 66 | 1.050 |
Why?
| Radiation Injuries, Experimental | 3 | 2013 | 25 | 0.990 |
Why?
| Wound Infection | 2 | 2016 | 30 | 0.980 |
Why?
| Postoperative Complications | 6 | 2018 | 2158 | 0.930 |
Why?
| Pneumonia, Bacterial | 2 | 2016 | 106 | 0.930 |
Why?
| Male | 72 | 2024 | 55811 | 0.920 |
Why?
| Liver | 9 | 2023 | 1688 | 0.910 |
Why?
| Skin | 6 | 2016 | 659 | 0.900 |
Why?
| Mice, Inbred BALB C | 12 | 2020 | 1155 | 0.880 |
Why?
| Humans | 93 | 2024 | 115219 | 0.850 |
Why?
| Biomedical Research | 4 | 2018 | 585 | 0.830 |
Why?
| Radiation Injuries | 2 | 2016 | 127 | 0.830 |
Why?
| Chemokines | 8 | 2023 | 213 | 0.820 |
Why?
| Signal Transduction | 14 | 2022 | 4527 | 0.800 |
Why?
| Delirium | 1 | 2023 | 66 | 0.800 |
Why?
| Pneumonia, Pneumococcal | 1 | 2022 | 38 | 0.800 |
Why?
| Biomarkers | 18 | 2024 | 3421 | 0.770 |
Why?
| Tight Junctions | 1 | 2021 | 68 | 0.760 |
Why?
| Pneumococcal Infections | 1 | 2022 | 91 | 0.760 |
Why?
| Immunity, Cellular | 5 | 2018 | 249 | 0.750 |
Why?
| Wounds and Injuries | 4 | 2015 | 723 | 0.740 |
Why?
| Astrocytes | 1 | 2022 | 162 | 0.740 |
Why?
| Female | 56 | 2024 | 59717 | 0.710 |
Why?
| Leukocytes | 3 | 2011 | 277 | 0.710 |
Why?
| Estrogens | 2 | 2016 | 317 | 0.700 |
Why?
| Pore Forming Cytotoxic Proteins | 1 | 2020 | 15 | 0.690 |
Why?
| von Willebrand Factor | 1 | 2019 | 56 | 0.680 |
Why?
| Intestinal Mucosa | 3 | 2021 | 528 | 0.680 |
Why?
| Epigenesis, Genetic | 4 | 2022 | 524 | 0.650 |
Why?
| Gastrointestinal Tract | 2 | 2020 | 169 | 0.650 |
Why?
| Allergy and Immunology | 2 | 2017 | 53 | 0.650 |
Why?
| Glycerophospholipids | 4 | 2021 | 27 | 0.640 |
Why?
| Pseudomonas aeruginosa | 5 | 2014 | 299 | 0.640 |
Why?
| Fatty Liver | 3 | 2017 | 217 | 0.640 |
Why?
| Hepatitis, Alcoholic | 1 | 2018 | 13 | 0.630 |
Why?
| Flow Cytometry | 6 | 2018 | 1084 | 0.620 |
Why?
| Immunosenescence | 2 | 2017 | 4 | 0.620 |
Why?
| Tumor Necrosis Factor-alpha | 6 | 2022 | 1138 | 0.620 |
Why?
| Mesenchymal Stem Cell Transplantation | 1 | 2018 | 37 | 0.620 |
Why?
| Pepsin A | 3 | 2014 | 18 | 0.620 |
Why?
| Aged | 24 | 2024 | 19135 | 0.610 |
Why?
| Prenatal Exposure Delayed Effects | 1 | 2023 | 450 | 0.580 |
Why?
| Length of Stay | 3 | 2019 | 951 | 0.580 |
Why?
| Feces | 1 | 2020 | 373 | 0.580 |
Why?
| Chemokine CCL2 | 1 | 2017 | 105 | 0.580 |
Why?
| Sepsis | 5 | 2023 | 508 | 0.580 |
Why?
| Tissue Donors | 3 | 2018 | 330 | 0.570 |
Why?
| Histone Deacetylase 1 | 1 | 2016 | 16 | 0.550 |
Why?
| Spleen | 5 | 2011 | 486 | 0.550 |
Why?
| Kupffer Cells | 1 | 2016 | 45 | 0.540 |
Why?
| Myosin-Light-Chain Kinase | 2 | 2014 | 19 | 0.530 |
Why?
| Laparoscopy | 5 | 2014 | 395 | 0.530 |
Why?
| Pulmonary Edema | 1 | 2016 | 116 | 0.530 |
Why?
| Microbiota | 1 | 2023 | 648 | 0.530 |
Why?
| Inflammation Mediators | 6 | 2015 | 476 | 0.530 |
Why?
| Middle Aged | 29 | 2022 | 26872 | 0.520 |
Why?
| Granulocyte Colony-Stimulating Factor | 2 | 2013 | 71 | 0.520 |
Why?
| Intestine, Small | 2 | 2016 | 125 | 0.510 |
Why?
| p38 Mitogen-Activated Protein Kinases | 1 | 2016 | 262 | 0.510 |
Why?
| Adaptive Immunity | 2 | 2016 | 156 | 0.510 |
Why?
| Bradykinin B2 Receptor Antagonists | 1 | 2015 | 1 | 0.500 |
Why?
| Immunologic Memory | 1 | 2017 | 313 | 0.490 |
Why?
| Extracellular Traps | 1 | 2015 | 40 | 0.490 |
Why?
| Bradykinin | 1 | 2015 | 43 | 0.490 |
Why?
| Models, Animal | 6 | 2019 | 349 | 0.490 |
Why?
| Dehydration | 1 | 2015 | 40 | 0.480 |
Why?
| Respiration | 1 | 2015 | 182 | 0.480 |
Why?
| Histones | 2 | 2016 | 535 | 0.480 |
Why?
| Primary Graft Dysfunction | 1 | 2014 | 32 | 0.470 |
Why?
| Oxidative Stress | 5 | 2017 | 1086 | 0.470 |
Why?
| Lipopolysaccharides | 5 | 2012 | 818 | 0.470 |
Why?
| Esophageal pH Monitoring | 1 | 2014 | 22 | 0.460 |
Why?
| Breath Tests | 3 | 2016 | 83 | 0.450 |
Why?
| Monocytes | 1 | 2016 | 503 | 0.440 |
Why?
| Dendritic Cells | 3 | 2016 | 436 | 0.430 |
Why?
| Scleroderma, Systemic | 1 | 2014 | 96 | 0.430 |
Why?
| Congresses as Topic | 4 | 2020 | 200 | 0.430 |
Why?
| Research Personnel | 1 | 2014 | 151 | 0.430 |
Why?
| Mentors | 1 | 2014 | 158 | 0.420 |
Why?
| Ileitis | 1 | 2013 | 26 | 0.420 |
Why?
| Graft Rejection | 2 | 2013 | 532 | 0.420 |
Why?
| Permeability | 3 | 2022 | 148 | 0.420 |
Why?
| Solvents | 1 | 2013 | 104 | 0.420 |
Why?
| Career Choice | 1 | 2014 | 183 | 0.420 |
Why?
| Chemotaxis, Leukocyte | 1 | 2013 | 129 | 0.420 |
Why?
| Staphylococcal Infections | 2 | 2013 | 337 | 0.410 |
Why?
| Leukocyte Count | 5 | 2013 | 292 | 0.410 |
Why?
| Intestinal Diseases | 1 | 2012 | 29 | 0.410 |
Why?
| Injury Severity Score | 5 | 2017 | 457 | 0.410 |
Why?
| Adult | 30 | 2021 | 30708 | 0.410 |
Why?
| rac GTP-Binding Proteins | 1 | 2012 | 34 | 0.400 |
Why?
| Prospective Studies | 9 | 2021 | 6245 | 0.400 |
Why?
| Phagosomes | 1 | 2012 | 40 | 0.400 |
Why?
| Fundoplication | 1 | 2012 | 51 | 0.400 |
Why?
| Receptors, IgG | 1 | 2012 | 67 | 0.390 |
Why?
| Ischemia | 1 | 2015 | 363 | 0.390 |
Why?
| Antibodies | 2 | 2013 | 372 | 0.390 |
Why?
| Alanine Transaminase | 4 | 2021 | 141 | 0.380 |
Why?
| Immunologic Factors | 2 | 2016 | 221 | 0.380 |
Why?
| Mice, Knockout | 7 | 2013 | 2586 | 0.380 |
Why?
| Logistic Models | 6 | 2019 | 1841 | 0.380 |
Why?
| Ligands | 2 | 2023 | 565 | 0.380 |
Why?
| Enzyme-Linked Immunosorbent Assay | 9 | 2018 | 796 | 0.370 |
Why?
| Immunity | 2 | 2010 | 121 | 0.370 |
Why?
| Toll-Like Receptor 4 | 2 | 2010 | 286 | 0.370 |
Why?
| Cause of Death | 3 | 2019 | 367 | 0.360 |
Why?
| Down-Regulation | 1 | 2013 | 598 | 0.360 |
Why?
| Cell Separation | 1 | 2011 | 291 | 0.360 |
Why?
| Environmental Pollutants | 1 | 2011 | 110 | 0.340 |
Why?
| Immune Tolerance | 1 | 2012 | 329 | 0.340 |
Why?
| Actins | 1 | 2012 | 383 | 0.340 |
Why?
| Intercellular Adhesion Molecule-1 | 1 | 2010 | 154 | 0.340 |
Why?
| Toll-Like Receptor 2 | 1 | 2010 | 109 | 0.340 |
Why?
| Receptors, Interleukin-8B | 2 | 2010 | 23 | 0.330 |
Why?
| Interleukin-12 | 2 | 2013 | 110 | 0.330 |
Why?
| Risk Factors | 11 | 2024 | 8658 | 0.310 |
Why?
| Illinois | 4 | 2017 | 37 | 0.310 |
Why?
| Time Factors | 9 | 2019 | 6157 | 0.310 |
Why?
| Occludin | 2 | 2021 | 10 | 0.310 |
Why?
| Respiration, Artificial | 1 | 2012 | 527 | 0.310 |
Why?
| Smoking | 2 | 2013 | 1392 | 0.300 |
Why?
| Chemokine CXCL1 | 2 | 2020 | 66 | 0.300 |
Why?
| Aspartate Aminotransferases | 2 | 2021 | 87 | 0.290 |
Why?
| Gastroenteritis | 1 | 2008 | 65 | 0.290 |
Why?
| Plethysmography | 2 | 2019 | 104 | 0.290 |
Why?
| Peptides | 1 | 2012 | 849 | 0.280 |
Why?
| Peroxidase | 3 | 2016 | 157 | 0.280 |
Why?
| Bronchoscopy | 3 | 2013 | 244 | 0.270 |
Why?
| Trachea | 1 | 2008 | 234 | 0.260 |
Why?
| Statistics, Nonparametric | 5 | 2013 | 387 | 0.260 |
Why?
| Retrospective Studies | 10 | 2023 | 12596 | 0.260 |
Why?
| Bacteria | 3 | 2023 | 728 | 0.260 |
Why?
| Apoptosis | 5 | 2023 | 2368 | 0.260 |
Why?
| Skin Ulcer | 2 | 2015 | 13 | 0.250 |
Why?
| Aged, 80 and over | 5 | 2017 | 6358 | 0.250 |
Why?
| ROC Curve | 5 | 2018 | 447 | 0.240 |
Why?
| Survival Analysis | 3 | 2019 | 1215 | 0.230 |
Why?
| Burn Units | 2 | 2022 | 26 | 0.230 |
Why?
| Hospital Mortality | 2 | 2019 | 776 | 0.230 |
Why?
| Exhalation | 2 | 2016 | 35 | 0.230 |
Why?
| Toxoplasma | 1 | 2024 | 30 | 0.230 |
Why?
| Toxoplasmosis | 1 | 2024 | 30 | 0.230 |
Why?
| Homeostasis | 2 | 2020 | 578 | 0.230 |
Why?
| Multivariate Analysis | 3 | 2023 | 1436 | 0.220 |
Why?
| Phenotype | 4 | 2020 | 2814 | 0.220 |
Why?
| Cohort Studies | 8 | 2019 | 4917 | 0.220 |
Why?
| Hawaii | 1 | 2023 | 38 | 0.220 |
Why?
| Sex Characteristics | 3 | 2016 | 639 | 0.220 |
Why?
| Zonula Occludens-1 Protein | 2 | 2013 | 13 | 0.210 |
Why?
| Critical Illness | 2 | 2018 | 645 | 0.210 |
Why?
| alpha-Defensins | 1 | 2022 | 11 | 0.210 |
Why?
| Whole-Body Irradiation | 2 | 2013 | 72 | 0.210 |
Why?
| Body Surface Area | 1 | 2022 | 27 | 0.210 |
Why?
| Neurodegenerative Diseases | 1 | 2023 | 91 | 0.200 |
Why?
| Veterans Health | 1 | 2024 | 165 | 0.200 |
Why?
| Caspases | 1 | 2023 | 245 | 0.200 |
Why?
| Fluorescent Antibody Technique | 3 | 2014 | 396 | 0.200 |
Why?
| Interleukin-1beta | 3 | 2020 | 370 | 0.190 |
Why?
| Colon | 1 | 2023 | 233 | 0.190 |
Why?
| Frailty | 1 | 2024 | 115 | 0.190 |
Why?
| Malondialdehyde | 1 | 2021 | 28 | 0.190 |
Why?
| Phosphorylation | 3 | 2016 | 1574 | 0.190 |
Why?
| Injections, Intraperitoneal | 2 | 2013 | 100 | 0.190 |
Why?
| Interleukins | 2 | 2014 | 236 | 0.190 |
Why?
| Streptococcus pneumoniae | 1 | 2022 | 134 | 0.190 |
Why?
| Lipid Peroxidation | 1 | 2021 | 139 | 0.180 |
Why?
| Analysis of Variance | 3 | 2014 | 1231 | 0.180 |
Why?
| Ventricular Dysfunction, Right | 1 | 2023 | 222 | 0.180 |
Why?
| Caspase 3 | 3 | 2023 | 237 | 0.180 |
Why?
| Boston | 1 | 2020 | 75 | 0.170 |
Why?
| Organ Specificity | 1 | 2020 | 270 | 0.170 |
Why?
| Resistin | 1 | 2019 | 12 | 0.170 |
Why?
| Gastric Inhibitory Polypeptide | 1 | 2019 | 14 | 0.170 |
Why?
| Metformin | 1 | 2023 | 278 | 0.170 |
Why?
| Predictive Value of Tests | 3 | 2019 | 1816 | 0.170 |
Why?
| Ghrelin | 1 | 2019 | 33 | 0.170 |
Why?
| Cognitive Dysfunction | 1 | 2023 | 273 | 0.170 |
Why?
| Risk Assessment | 5 | 2019 | 2981 | 0.170 |
Why?
| Cells, Cultured | 7 | 2016 | 3897 | 0.170 |
Why?
| Glutathione | 1 | 2021 | 302 | 0.170 |
Why?
| Mannose-Binding Lectins | 1 | 2019 | 13 | 0.170 |
Why?
| Proteasome Endopeptidase Complex | 2 | 2010 | 135 | 0.170 |
Why?
| Plasminogen Activator Inhibitor 1 | 1 | 2019 | 82 | 0.170 |
Why?
| Natural Killer T-Cells | 2 | 2010 | 63 | 0.160 |
Why?
| Lectins, C-Type | 1 | 2019 | 61 | 0.160 |
Why?
| Fires | 1 | 2020 | 74 | 0.160 |
Why?
| Prognosis | 3 | 2018 | 3336 | 0.160 |
Why?
| Cell Count | 2 | 2016 | 304 | 0.160 |
Why?
| Administration, Oral | 2 | 2013 | 731 | 0.160 |
Why?
| Multiple Organ Failure | 2 | 2017 | 143 | 0.160 |
Why?
| Glucagon-Like Peptide 1 | 1 | 2019 | 101 | 0.160 |
Why?
| In Situ Nick-End Labeling | 1 | 2018 | 119 | 0.160 |
Why?
| Intensive Care Units | 4 | 2019 | 618 | 0.160 |
Why?
| Leptin | 1 | 2019 | 212 | 0.150 |
Why?
| Antimicrobial Cationic Peptides | 1 | 2018 | 75 | 0.150 |
Why?
| Hippocampus | 1 | 2022 | 697 | 0.150 |
Why?
| Transcriptome | 1 | 2023 | 725 | 0.150 |
Why?
| Toll-Like Receptors | 2 | 2009 | 166 | 0.150 |
Why?
| RNA, Ribosomal, 16S | 1 | 2020 | 487 | 0.150 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 928 | 0.150 |
Why?
| Reproducibility of Results | 2 | 2019 | 2806 | 0.150 |
Why?
| Young Adult | 7 | 2018 | 10519 | 0.150 |
Why?
| Needs Assessment | 1 | 2019 | 317 | 0.150 |
Why?
| Follow-Up Studies | 2 | 2018 | 4430 | 0.140 |
Why?
| Receptors, Cell Surface | 1 | 2019 | 356 | 0.140 |
Why?
| Tobacco Use | 1 | 2017 | 61 | 0.140 |
Why?
| Respiratory Function Tests | 2 | 2015 | 523 | 0.140 |
Why?
| Incidence | 3 | 2019 | 2324 | 0.140 |
Why?
| Phylogeny | 1 | 2020 | 796 | 0.130 |
Why?
| Ovariectomy | 1 | 2016 | 117 | 0.130 |
Why?
| Acetylation | 1 | 2016 | 211 | 0.130 |
Why?
| Dose-Response Relationship, Drug | 3 | 2010 | 1860 | 0.130 |
Why?
| United States | 9 | 2024 | 12256 | 0.130 |
Why?
| Monocyte Chemoattractant Proteins | 1 | 2015 | 8 | 0.130 |
Why?
| Cognition | 1 | 2023 | 982 | 0.130 |
Why?
| Chemokine CXCL2 | 1 | 2015 | 37 | 0.130 |
Why?
| Insulin | 2 | 2019 | 2083 | 0.130 |
Why?
| Polymerase Chain Reaction | 1 | 2018 | 1000 | 0.130 |
Why?
| Imidazoles | 1 | 2016 | 209 | 0.130 |
Why?
| Apicomplexa | 1 | 2015 | 2 | 0.130 |
Why?
| Regression Analysis | 3 | 2013 | 949 | 0.130 |
Why?
| Killer Cells, Natural | 2 | 2008 | 383 | 0.120 |
Why?
| Linear Models | 1 | 2017 | 779 | 0.120 |
Why?
| Negative-Pressure Wound Therapy | 1 | 2015 | 13 | 0.120 |
Why?
| Enzyme Inhibitors | 2 | 2016 | 753 | 0.120 |
Why?
| Radiation Dosage | 1 | 2016 | 138 | 0.120 |
Why?
| Hematocrit | 1 | 2015 | 85 | 0.120 |
Why?
| Sex Factors | 4 | 2019 | 1722 | 0.120 |
Why?
| Respiratory Tract Diseases | 1 | 2016 | 140 | 0.120 |
Why?
| Systemic Inflammatory Response Syndrome | 2 | 2014 | 71 | 0.120 |
Why?
| Alcohol-Related Disorders | 1 | 2015 | 113 | 0.120 |
Why?
| Electric Stimulation Therapy | 1 | 2015 | 56 | 0.120 |
Why?
| Gene Expression | 2 | 2018 | 1424 | 0.120 |
Why?
| Interleukin-23 | 1 | 2014 | 15 | 0.120 |
Why?
| Chi-Square Distribution | 2 | 2013 | 498 | 0.120 |
Why?
| Leukocyte Disorders | 1 | 2014 | 11 | 0.120 |
Why?
| Lung Injury | 1 | 2016 | 198 | 0.110 |
Why?
| Fungi | 1 | 2015 | 124 | 0.110 |
Why?
| Viruses | 1 | 2015 | 94 | 0.110 |
Why?
| Receptors, Aryl Hydrocarbon | 1 | 2014 | 39 | 0.110 |
Why?
| Immune System Diseases | 1 | 2014 | 34 | 0.110 |
Why?
| Caspase 8 | 1 | 2013 | 43 | 0.110 |
Why?
| Th17 Cells | 1 | 2014 | 59 | 0.110 |
Why?
| Faculty | 1 | 2014 | 131 | 0.110 |
Why?
| Lymphocyte Subsets | 1 | 2013 | 79 | 0.110 |
Why?
| Ileum | 1 | 2013 | 92 | 0.110 |
Why?
| Employment | 1 | 2014 | 139 | 0.110 |
Why?
| Adipose Tissue | 2 | 2015 | 558 | 0.110 |
Why?
| Myosin Light Chains | 1 | 2013 | 26 | 0.110 |
Why?
| Creatinine | 1 | 2015 | 428 | 0.110 |
Why?
| Pyridines | 1 | 2016 | 424 | 0.110 |
Why?
| Veterans | 1 | 2024 | 1234 | 0.110 |
Why?
| Pregnancy | 2 | 2023 | 5525 | 0.110 |
Why?
| Immunoassay | 1 | 2013 | 95 | 0.110 |
Why?
| Bile Acids and Salts | 1 | 2014 | 172 | 0.100 |
Why?
| Cell Differentiation | 2 | 2016 | 1700 | 0.100 |
Why?
| Calcitonin | 1 | 2012 | 23 | 0.100 |
Why?
| Bacterial Load | 1 | 2012 | 58 | 0.100 |
Why?
| Anti-Infective Agents | 1 | 2015 | 225 | 0.100 |
Why?
| Syndrome | 1 | 2013 | 338 | 0.100 |
Why?
| Vinculin | 1 | 2012 | 10 | 0.100 |
Why?
| Hypertension, Pulmonary | 1 | 2023 | 1744 | 0.100 |
Why?
| Blood Glucose | 2 | 2019 | 1823 | 0.100 |
Why?
| Paxillin | 1 | 2012 | 10 | 0.100 |
Why?
| Receptors, Interleukin-4 | 1 | 2011 | 15 | 0.100 |
Why?
| Interleukin 1 Receptor Antagonist Protein | 1 | 2013 | 254 | 0.100 |
Why?
| Chorionic Villi | 1 | 1992 | 16 | 0.100 |
Why?
| Decidua | 1 | 1992 | 23 | 0.100 |
Why?
| Receptors, Interleukin-2 | 1 | 1992 | 64 | 0.100 |
Why?
| Focal Adhesions | 1 | 2012 | 42 | 0.100 |
Why?
| Ubiquitin | 1 | 2012 | 58 | 0.100 |
Why?
| Protein Precursors | 1 | 2012 | 119 | 0.100 |
Why?
| Chemokine CXCL12 | 1 | 2012 | 74 | 0.100 |
Why?
| rho GTP-Binding Proteins | 1 | 2012 | 61 | 0.100 |
Why?
| Nitric Oxide Synthase Type II | 1 | 2011 | 157 | 0.100 |
Why?
| Polymerization | 1 | 2012 | 119 | 0.090 |
Why?
| Vehicle Emissions | 1 | 2011 | 48 | 0.090 |
Why?
| Phagocytes | 2 | 2009 | 90 | 0.090 |
Why?
| Confidence Intervals | 1 | 2012 | 307 | 0.090 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 271 | 0.090 |
Why?
| Research Support as Topic | 1 | 2012 | 108 | 0.090 |
Why?
| Pulmonary Alveoli | 1 | 2013 | 374 | 0.090 |
Why?
| Specimen Handling | 1 | 2012 | 155 | 0.090 |
Why?
| Tissue Engineering | 1 | 2015 | 366 | 0.090 |
Why?
| Nitric Oxide | 1 | 2016 | 827 | 0.090 |
Why?
| Adolescent | 5 | 2017 | 17887 | 0.090 |
Why?
| Cytoskeleton | 1 | 2012 | 177 | 0.090 |
Why?
| Bone Marrow Cells | 1 | 2011 | 267 | 0.090 |
Why?
| Bacteremia | 1 | 2012 | 159 | 0.090 |
Why?
| Writing | 1 | 2012 | 85 | 0.090 |
Why?
| Edema | 1 | 2011 | 119 | 0.090 |
Why?
| Ozone | 1 | 2011 | 99 | 0.090 |
Why?
| Immunohistochemistry | 1 | 2015 | 1635 | 0.090 |
Why?
| Mass Screening | 2 | 2015 | 1011 | 0.090 |
Why?
| Heart Failure | 1 | 2023 | 1962 | 0.090 |
Why?
| Dermatitis | 1 | 2010 | 17 | 0.090 |
Why?
| Trophoblasts | 1 | 1992 | 162 | 0.090 |
Why?
| Equipment Design | 1 | 2012 | 513 | 0.090 |
Why?
| Cystic Fibrosis | 1 | 2019 | 957 | 0.090 |
Why?
| DNA | 2 | 2015 | 1353 | 0.090 |
Why?
| Endoscopy, Gastrointestinal | 1 | 2011 | 202 | 0.080 |
Why?
| Respiration Disorders | 1 | 2010 | 68 | 0.080 |
Why?
| Severity of Illness Index | 2 | 2019 | 2552 | 0.080 |
Why?
| Odds Ratio | 1 | 2012 | 958 | 0.080 |
Why?
| Interleukin-18 | 1 | 2010 | 219 | 0.080 |
Why?
| Protein Kinase Inhibitors | 1 | 2014 | 787 | 0.080 |
Why?
| Histiocytes | 1 | 2008 | 6 | 0.080 |
Why?
| Kaplan-Meier Estimate | 1 | 2011 | 816 | 0.080 |
Why?
| Escherichia coli K12 | 1 | 2008 | 7 | 0.080 |
Why?
| Membrane Fluidity | 1 | 2008 | 10 | 0.080 |
Why?
| Hypersensitivity, Delayed | 1 | 2008 | 31 | 0.080 |
Why?
| Acute Lung Injury | 1 | 2012 | 300 | 0.080 |
Why?
| Interleukin-2 | 1 | 2009 | 415 | 0.080 |
Why?
| Comorbidity | 3 | 2019 | 1458 | 0.080 |
Why?
| Membrane Microdomains | 1 | 2008 | 32 | 0.080 |
Why?
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2008 | 12 | 0.080 |
Why?
| Shock | 1 | 2009 | 76 | 0.080 |
Why?
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2008 | 86 | 0.080 |
Why?
| Manometry | 3 | 2013 | 89 | 0.080 |
Why?
| Opportunistic Infections | 1 | 2008 | 43 | 0.070 |
Why?
| Staphylococcus aureus | 1 | 2011 | 386 | 0.070 |
Why?
| Survival Rate | 1 | 2012 | 1650 | 0.070 |
Why?
| Capillary Permeability | 1 | 2008 | 136 | 0.070 |
Why?
| Testis | 1 | 2008 | 133 | 0.070 |
Why?
| Intubation, Gastrointestinal | 1 | 2008 | 53 | 0.070 |
Why?
| Mast Cells | 1 | 2008 | 117 | 0.070 |
Why?
| Protein Kinases | 1 | 2009 | 307 | 0.070 |
Why?
| Idiopathic Pulmonary Fibrosis | 1 | 2013 | 510 | 0.070 |
Why?
| Hypothalamo-Hypophyseal System | 1 | 2008 | 164 | 0.070 |
Why?
| Treatment Outcome | 2 | 2012 | 9151 | 0.070 |
Why?
| Neovascularization, Physiologic | 1 | 2008 | 173 | 0.070 |
Why?
| Asthma | 2 | 2016 | 2051 | 0.070 |
Why?
| Hydrogen-Ion Concentration | 3 | 2013 | 512 | 0.070 |
Why?
| Reproduction | 1 | 2008 | 179 | 0.070 |
Why?
| Gonadal Steroid Hormones | 1 | 2008 | 124 | 0.070 |
Why?
| Angiogenesis Inhibitors | 1 | 2008 | 214 | 0.070 |
Why?
| In Vitro Techniques | 1 | 2008 | 1036 | 0.070 |
Why?
| Cell Communication | 1 | 2008 | 280 | 0.070 |
Why?
| Cell Line | 1 | 2012 | 2645 | 0.070 |
Why?
| Interferon-gamma | 1 | 2009 | 724 | 0.070 |
Why?
| Eosinophils | 1 | 2008 | 281 | 0.070 |
Why?
| Research Design | 1 | 2012 | 933 | 0.070 |
Why?
| Neoplasms | 2 | 2016 | 2106 | 0.070 |
Why?
| Interleukin-1 | 1 | 2010 | 970 | 0.070 |
Why?
| Sensitivity and Specificity | 3 | 2018 | 1717 | 0.060 |
Why?
| Life Style | 1 | 2008 | 431 | 0.060 |
Why?
| Anti-Bacterial Agents | 1 | 2014 | 1481 | 0.060 |
Why?
| Acute Disease | 1 | 2008 | 918 | 0.060 |
Why?
| Hemorrhage | 1 | 2009 | 618 | 0.060 |
Why?
| Barrett Esophagus | 3 | 2012 | 147 | 0.060 |
Why?
| Polymorphism, Genetic | 1 | 2008 | 618 | 0.060 |
Why?
| Lomustine | 1 | 2024 | 14 | 0.060 |
Why?
| Anti-Inflammatory Agents | 1 | 2008 | 451 | 0.060 |
Why?
| Surveys and Questionnaires | 4 | 2019 | 4645 | 0.060 |
Why?
| Case-Control Studies | 4 | 2015 | 3023 | 0.060 |
Why?
| Antibodies, Protozoan | 1 | 2024 | 29 | 0.060 |
Why?
| Antioxidants | 1 | 2008 | 530 | 0.060 |
Why?
| Caspase 9 | 1 | 2023 | 48 | 0.050 |
Why?
| Prednisone | 1 | 2024 | 233 | 0.050 |
Why?
| Endothelial Cells | 1 | 2008 | 686 | 0.050 |
Why?
| Energy Metabolism | 1 | 2008 | 730 | 0.050 |
Why?
| Immunoglobulin M | 1 | 2024 | 252 | 0.050 |
Why?
| DNA Repair | 1 | 1984 | 186 | 0.050 |
Why?
| Lymphocytes | 1 | 1984 | 335 | 0.050 |
Why?
| Virulence | 1 | 2023 | 228 | 0.050 |
Why?
| AMP-Activated Protein Kinases | 1 | 2023 | 175 | 0.050 |
Why?
| Liver Cirrhosis | 1 | 2023 | 238 | 0.050 |
Why?
| Colorado | 2 | 2024 | 4099 | 0.050 |
Why?
| Hernia, Hiatal | 2 | 2012 | 32 | 0.050 |
Why?
| Ventricular Remodeling | 1 | 2023 | 227 | 0.050 |
Why?
| Blood Alcohol Content | 1 | 2021 | 5 | 0.050 |
Why?
| Ventricular Function, Right | 1 | 2023 | 254 | 0.050 |
Why?
| United States Department of Veterans Affairs | 1 | 2024 | 557 | 0.040 |
Why?
| Immunoglobulin G | 1 | 2024 | 775 | 0.040 |
Why?
| Firefighters | 1 | 2020 | 38 | 0.040 |
Why?
| Patient Care Team | 1 | 2024 | 516 | 0.040 |
Why?
| Chronic Disease | 2 | 2015 | 1593 | 0.040 |
Why?
| Cathelicidins | 1 | 2018 | 38 | 0.040 |
Why?
| Patient-Centered Care | 1 | 2024 | 474 | 0.040 |
Why?
| Disease Progression | 2 | 2015 | 2390 | 0.040 |
Why?
| Vascular Endothelial Growth Factor A | 2 | 2013 | 499 | 0.040 |
Why?
| Half-Life | 1 | 2018 | 143 | 0.040 |
Why?
| California | 1 | 2019 | 364 | 0.040 |
Why?
| Age of Onset | 1 | 2019 | 449 | 0.040 |
Why?
| Reference Standards | 1 | 2018 | 160 | 0.040 |
Why?
| Reference Values | 1 | 2019 | 748 | 0.040 |
Why?
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2017 | 94 | 0.040 |
Why?
| Shock, Septic | 1 | 2019 | 186 | 0.040 |
Why?
| Dried Blood Spot Testing | 1 | 2017 | 71 | 0.040 |
Why?
| Forkhead Box Protein O3 | 1 | 2016 | 13 | 0.030 |
Why?
| International Classification of Diseases | 1 | 2017 | 116 | 0.030 |
Why?
| Gene Expression Profiling | 1 | 2023 | 1524 | 0.030 |
Why?
| Academic Medical Centers | 1 | 2019 | 412 | 0.030 |
Why?
| Propensity Score | 1 | 2017 | 224 | 0.030 |
Why?
| Bronchoalveolar Lavage | 1 | 2015 | 84 | 0.030 |
Why?
| Rats | 3 | 2014 | 4980 | 0.030 |
Why?
| Self Report | 1 | 2019 | 699 | 0.030 |
Why?
| Critical Care | 1 | 2019 | 476 | 0.030 |
Why?
| Psoriasis | 1 | 2015 | 74 | 0.030 |
Why?
| Histocompatibility Antigens Class II | 1 | 2016 | 353 | 0.030 |
Why?
| Administration, Topical | 1 | 2015 | 138 | 0.030 |
Why?
| Endocrine System | 1 | 2014 | 19 | 0.030 |
Why?
| Prevalence | 2 | 2011 | 2257 | 0.030 |
Why?
| Hemostasis | 1 | 2014 | 67 | 0.030 |
Why?
| Canada | 1 | 2015 | 323 | 0.030 |
Why?
| C-Reactive Protein | 1 | 2016 | 363 | 0.030 |
Why?
| Cross-Sectional Studies | 1 | 2024 | 4419 | 0.030 |
Why?
| Pneumonia, Aspiration | 1 | 2013 | 15 | 0.030 |
Why?
| Virus Diseases | 1 | 2015 | 196 | 0.030 |
Why?
| Forecasting | 1 | 2015 | 333 | 0.030 |
Why?
| Chemokine CCL5 | 1 | 2013 | 45 | 0.030 |
Why?
| Area Under Curve | 1 | 2014 | 275 | 0.030 |
Why?
| Metabolomics | 1 | 2017 | 527 | 0.030 |
Why?
| Societies, Medical | 1 | 2016 | 680 | 0.030 |
Why?
| Gene Expression Regulation | 2 | 2013 | 2330 | 0.030 |
Why?
| Disease Management | 1 | 2016 | 562 | 0.030 |
Why?
| Calcitonin Gene-Related Peptide | 1 | 2012 | 32 | 0.030 |
Why?
| Acute-Phase Proteins | 1 | 2012 | 64 | 0.030 |
Why?
| Cell Survival | 1 | 2015 | 1022 | 0.030 |
Why?
| Diagnosis, Differential | 1 | 2016 | 1356 | 0.030 |
Why?
| Technetium Tc 99m Sulfur Colloid | 1 | 2012 | 6 | 0.030 |
Why?
| Barium Sulfate | 1 | 2012 | 15 | 0.030 |
Why?
| Fluorescence | 1 | 2012 | 148 | 0.020 |
Why?
| Gastric Emptying | 1 | 2012 | 40 | 0.020 |
Why?
| Pregnancy Trimester, First | 1 | 1992 | 127 | 0.020 |
Why?
| Radiopharmaceuticals | 1 | 2012 | 164 | 0.020 |
Why?
| Monitoring, Ambulatory | 1 | 2012 | 80 | 0.020 |
Why?
| T-Lymphocytes, Helper-Inducer | 1 | 1992 | 128 | 0.020 |
Why?
| Esophagitis | 1 | 2011 | 65 | 0.020 |
Why?
| DNA Fragmentation | 1 | 2010 | 47 | 0.020 |
Why?
| bcl-X Protein | 1 | 2010 | 38 | 0.020 |
Why?
| bcl-2-Associated X Protein | 1 | 2010 | 45 | 0.020 |
Why?
| Liver Transplantation | 1 | 2018 | 831 | 0.020 |
Why?
| Drug Administration Routes | 1 | 2010 | 40 | 0.020 |
Why?
| Abortion, Induced | 1 | 1992 | 71 | 0.020 |
Why?
| Pneumonia, Viral | 1 | 2015 | 342 | 0.020 |
Why?
| Morbidity | 1 | 2011 | 279 | 0.020 |
Why?
| Membrane Glycoproteins | 1 | 2012 | 429 | 0.020 |
Why?
| Chromatography, Gel | 1 | 2009 | 125 | 0.020 |
Why?
| Antigens, CD1d | 1 | 2009 | 63 | 0.020 |
Why?
| Reoperation | 1 | 2012 | 524 | 0.020 |
Why?
| Esophagus | 1 | 2011 | 226 | 0.020 |
Why?
| Radiography | 1 | 2012 | 827 | 0.020 |
Why?
| Cell Movement | 1 | 2013 | 866 | 0.020 |
Why?
| Contrast Media | 1 | 2012 | 369 | 0.020 |
Why?
| T-Lymphocytes, Regulatory | 1 | 1992 | 340 | 0.020 |
Why?
| Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 929 | 0.020 |
Why?
| Nursing Assessment | 1 | 2009 | 48 | 0.020 |
Why?
| Transforming Growth Factor beta1 | 1 | 2009 | 154 | 0.020 |
Why?
| Antibodies, Neutralizing | 1 | 2010 | 221 | 0.020 |
Why?
| tert-Butyl Alcohol | 1 | 2008 | 1 | 0.020 |
Why?
| Alcohol Dehydrogenase | 1 | 2008 | 16 | 0.020 |
Why?
| Carrier Proteins | 1 | 2012 | 696 | 0.020 |
Why?
| Transforming Growth Factor beta | 1 | 1991 | 448 | 0.020 |
Why?
| Oligopeptides | 1 | 2010 | 234 | 0.020 |
Why?
| Drug Administration Schedule | 1 | 2010 | 721 | 0.020 |
Why?
| Collagen | 1 | 2009 | 416 | 0.020 |
Why?
| Cell Hypoxia | 1 | 2008 | 220 | 0.020 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2008 | 249 | 0.020 |
Why?
| Fibroblasts | 1 | 1991 | 839 | 0.020 |
Why?
| Lymphocyte Activation | 1 | 2010 | 1042 | 0.020 |
Why?
| Risk-Taking | 1 | 2009 | 333 | 0.020 |
Why?
| T-Lymphocytes | 1 | 2013 | 1748 | 0.020 |
Why?
| Rats, Sprague-Dawley | 1 | 2010 | 2216 | 0.020 |
Why?
| Cell Nucleus | 1 | 2008 | 556 | 0.020 |
Why?
| Pyrazoles | 1 | 2008 | 361 | 0.020 |
Why?
| Testosterone | 1 | 2008 | 343 | 0.020 |
Why?
| Hydroxyurea | 1 | 1984 | 30 | 0.010 |
Why?
| Quality of Life | 1 | 2015 | 2364 | 0.010 |
Why?
| Brain | 1 | 2015 | 2378 | 0.010 |
Why?
| Ultraviolet Rays | 1 | 1984 | 368 | 0.010 |
Why?
| Registries | 1 | 2008 | 1765 | 0.010 |
Why?
| Bleomycin | 1 | 1991 | 228 | 0.010 |
Why?
| Oxygen | 1 | 1991 | 855 | 0.000 |
Why?
| RNA, Messenger | 1 | 1991 | 2563 | 0.000 |
Why?
|
|
Kovacs's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|